Canada Pension Plan Investment Board
ADMA icon

Canada Pension Plan Investment Board’s ADMA Biologics ADMA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Buy
+42,200
New +$385K ﹤0.01% 1395
2025
Q2 		– Sell
-13,500
Closed -$268K – 1348
2025
Q1 		$268K Buy
+13,500
New +$233K ﹤0.01% 1017
2024
Q3 		– Sell
-260,200
Closed -$2.91M – 1322
2024
Q2 		$2.91M Buy
+260,200
New +$2.18M ﹤0.01% 823

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Canada Pension Plan Investment Board's ADMA Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in ADMA Biologics (ADMA) in Q2 2026: 42,200 shares worth $353K. The stake represents ﹤0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in ADMA as recently as Q1 2025.

Canada Pension Plan Investment Board first reported a position in ADMA in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.91M in Q2 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Canada Pension Plan Investment Board held 42,200 shares of ADMA Biologics worth $353K as of Q2 2026.
  • ADMA Biologics was a new Canada Pension Plan Investment Board position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1395 holding.
  • Canada Pension Plan Investment Board first reported a position in ADMA Biologics in Q2 2024 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's ADMA Biologics position peaked at $2.91M in Q2 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.